5‐year follow‐up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|121|15|2537-2543

ISSN: 0008-543x

Source: CANCER, Vol.121, Iss.15, 2015-08, pp. : 2537-2543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content